Cancer Centers of America works on TAPUR trials
The Cancer Centers of America takes the lead in cancer treatments and research. The organization recently participated in the TAPUR trials. TAPUR stands for targeted agent profiling and utilization registry. The acronym seems like it might have a long, complicated explanation, but the idea is quite simple. Researchers in this trial are not looking at dozens of patients with different types of cancer, they are looking at the same type of cancer in different patients. The study requires that the researcher find gene mutation specific to each cancer type.
The goal of this research is to make sure each patient gets the appropriate drugs for their cancer. By targeting specific mutations, the doctors treating the patient can recommend the best drug or combination of drugs to keep the cancerous cells from reproducing unchecked. Several rounds of chemotherapy may cause some patients to go in remission. More complex cases require more complex treatments. A patient whose case is severe may need to undergo radiation treatment and possibly surgery. It depends on the size of the cancer and how far it has spread.
Targeting the mutations that cause each type of cancer is part of the organization’s ongoing dedication to making sure each patient receives the treatment that is best for him or her. No one comes to the Cancer Centers of America expecting a one-size-fits-all approach. By conducting research to better target each of the 200 known cancer types, the staff can make sure each patient gets the best treatment possible.